P-1362. Cefiderocol Activity against Carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex, Including Molecularly Characterized Clinical Isolates, Causing Infections i... von Mendes, Rodrigo E, Scullin, Abigail, Kimbrough, Hank, Karr, Maura, Maher, Joshua, Hubler, Cory, Castanheira, Mariana

Volltext

P-1361. Cefiderocol Activity against Pseudomonas aeruginosa , Including Resistant Subsets and Isolates Carrying Carbapenemase β-lactamase Genes, from United States Hospitals (2020–... von Mendes, Rodrigo E, Maher, Joshua, Hubler, Cory, Scullin, Abigail, Karr, Maura, Kimbrough, Hank, Castanheira, Mariana

Volltext

P-1059. In vitro Activity of Gepotidacin against Klebsiella pneumoniae , Including Molecularly Characterized ESBL and Carbapenemase positive Subsets Causing Urinary Tract Infection... von Mendes, Rodrigo E, Scullin, Abigail, Kimbrough, Hank, Hubler, Cory, Kapoor, Renuka, Torumkuney, Didem, Ryan Arends, S J

Volltext

P-1060. In vitro Activity of Gepotidacin Tested Against Molecularly Characterized Escherichia coli Isolates Responsible for Urinary Tract Infections in the US (2019-2022) von Mendes, Rodrigo E, Beekman, Danielle, Scullin, Abigail, Karr, Maura, Kapoor, Renuka, Torumkuney, Didem, Ryan Arends, S J

Volltext